Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

312 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of Medication Nonadherence in a Clinical Trial of Dual Antiplatelet Therapy.
Valgimigli M, Frigoli E, Vranckx P, Ozaki Y, Morice MC, Chevalier B, Onuma Y, Windecker S, Delorme L, Kala P, Kedev S, Abhaichand RK, Velchev V, Dewilde W, Podolec J, Leibundgut G, Topic D, Schultz C, Stankovic G, Lee A, Johnson T, Tonino PAL, Klotzka A, Lesiak M, Lopes RD, Smits PC, Heg D; MASTER DAPT Investigators. Valgimigli M, et al. Among authors: vranckx p. J Am Coll Cardiol. 2022 Aug 23;80(8):766-778. doi: 10.1016/j.jacc.2022.04.065. J Am Coll Cardiol. 2022. PMID: 35981821 Free article. Clinical Trial.
Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.
Daemen J, Kuck KH, Macaya C, LeGrand V, Vrolix M, Carrie D, Sheiban I, Suttorp MJ, Vranckx P, Rademaker T, Goedhart D, Schuijer M, Wittebols K, Macours N, Stoll HP, Serruys PW; ARTS-II Investigators. Daemen J, et al. Among authors: vranckx p. J Am Coll Cardiol. 2008 Dec 9;52(24):1957-67. doi: 10.1016/j.jacc.2008.09.010. J Am Coll Cardiol. 2008. PMID: 19055986 Free article. Clinical Trial.
Three-year follow-up of the ARTS-II# - sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease.
Serruys PW, Daemen J, Morice MC, De Bruyne B, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Dawkins KD, Vranckx P, Bressers M, van Domburg R, Schuijer M, Wittebols K, Pieters M, Stoll HP. Serruys PW, et al. Among authors: vranckx p. EuroIntervention. 2008 Jan;3(4):450-9. doi: 10.4244/eijv3i4a81. EuroIntervention. 2008. PMID: 19736087
5-year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions.
Serruys PW, Onuma Y, Garg S, Vranckx P, De Bruyne B, Morice MC, Colombo A, Macaya C, Richardt G, Fajadet J, Hamm C, Schuijer M, Rademaker T, Wittebols K, Stoll HP; ARTS II Investigators. Serruys PW, et al. Among authors: vranckx p. J Am Coll Cardiol. 2010 Mar 16;55(11):1093-101. doi: 10.1016/j.jacc.2009.11.049. Epub 2010 Feb 18. J Am Coll Cardiol. 2010. PMID: 20171036 Free article. Clinical Trial.
5-Year follow-up of coronary revascularization in diabetic patients with multivessel coronary artery disease: insights from ARTS (arterial revascularization therapy study)-II and ARTS-I trials.
Onuma Y, Wykrzykowska JJ, Garg S, Vranckx P, Serruys PW; ARTS I and II Investigators. Onuma Y, et al. Among authors: vranckx p. JACC Cardiovasc Interv. 2011 Mar;4(3):317-23. doi: 10.1016/j.jcin.2010.12.004. JACC Cardiovasc Interv. 2011. PMID: 21435610 Free article. Clinical Trial.
312 results